JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Cells / Cell Lines

HighQC Human IPSC From Foreskin Fibroblast (Morbus Niemann Pick Type C)

SKU : BHC18002915

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

AcceGen Biotech

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	ABC-SC0020T
Description	iPSC (induced Pluripotent Stem cells) reprogrammed from cells of a patient with Morbus Niemann Pick type C.This iPS cell line was created using target cells from a patient suffering from MOrbus Niemann Pick type C.Gender: Male;Age: 11 years.The iPS cell line was generated using an episomal reprogramming containing a prprietary mix of vectors, containing Oct-4, Sox-2, Klf-4 along with p53 Anti-sense, EBNA-1.Cells are grown under feeder-free conditions and routinely grown in iPS Growth media. iPS cells are validated for pluripotency based on colony morphology, alkaline phosphatase expression, and expression of SSEA-4.iPS colonies exhibit classical morphology and growth.Absence of Mycoplasma was confirmed.The cell line is shipped on dry ice.
Categories	Stem Cells
Application	For research use only
Species	Human

Shipping	Dry Ice
Storage	Liquid Nitrogen

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Your price	Quantity
BHC18002915	ABC-SC0020T	-		Add to Quote

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.